期刊文献+

2004-2013年江苏省性病监测点丙肝疫情分析 被引量:11

Hepatitis C analysis of sentinel surveillance of STD in Jiangsu Provnice,2004-2013
下载PDF
导出
摘要 目的了解江苏省6个性病监测点丙型肝炎(丙肝)发病情况及特征,为制定防制策略提供依据。方法收集2004-2013年江苏6个性病监测点丙肝的报告病例资料,进行流行病学统计分析。结果2004-2013年,6个监测点共报告丙肝844例,年均发病率1.55/10万,且从2004年的1.09/10万上升至2013年2.47/10万,年均增长率为9.52%。男性病例数多于女性,男女比为1.34∶1,≥20岁年龄组占97.16%,工人、农民及牧民占70.50%。6个监测点丙肝发病率依次为金坛(4.21/10万)、太仓(2.14/10万)、楚州(1.62/10万)、沛县(1.36/10万)、射阳(0.83/10万)、启东(0.82/10万)。结论性病监测点中丙肝疫情特征与江苏省丙肝疫情特征较一致,男性青壮年工人、农民、牧民等是防制重点人群。 Objective To know the incidence and characteristics of the hepatitis C (HCV) in Six sentinel surveillance of STD, and provide scientific reference for outlining strategy of prevention and control of the disease. Methods Case-reporting data of hepatitis C in six sentinel surveillance of STD from 2004 to 2013 were collected, and data were undertaken by statistical analysis of epidemiology. Results The total number of reported cases were 844 from 2004 to 2013, the average incidence was 1.55/10 000 per year. The rate of incidence increased from 1.09/100 000 in 2004 to 2.47/100 000 in 2013,the rate of average growth per annum was 9.52%. The numbers of male cases were more than females; ratio of male to female was 1.34:1. The proportion of ages over or at 20 years was 97.16 %, of which workers, farmers and herdsmen were 70.50 %. The incidence of HCV in six sentinel surveillance of STD in order were Jintan (4.21/100 000), Taicang (2. 14/100 000), Chuzhou (1. 62/ 100 000), Peixian (1.36/100 000), Sheyang (0.83/100 000) and Qidong(0.82/100 000). Conclusion The epidemic situation of HCV in six sentinel surveillance of STD is in accordance with it in Jiangsu Province. Young male of workers, farmers and herdsmen are key groups in prevention and control of HCV.
出处 《江苏预防医学》 CAS 2014年第5期27-29,共3页 Jiangsu Journal of Preventive Medicine
基金 江苏省预防医学基金项目(Y201029 Y2012069)
关键词 丙型肝炎 哨点监测 疫情分析 流行病学 hepatitis C sentinel surveillance epidemic situation analysis epidemiology
  • 相关文献

参考文献9

二级参考文献26

  • 1牟怀德,陈霞,刘昕亮,吴薇,李丹.吸毒人群丙肝感染现状研究[J].现代预防医学,2006,33(10):1752-1753. 被引量:40
  • 2康富标,赵敏.丙型肝炎抗病毒治疗研究进展[J].中华肝脏病杂志,2006,14(12):933-935. 被引量:50
  • 3盛新民,王军,陈伯忠.献血员抗-HCV检测报告[J].微生物学免疫学进展,1996,24(3):15-16. 被引量:3
  • 4Hisada M,Chatterjee N,Kalaylioglu Z,et al.Hepatitis C virus load and survival among injection drug users in the United States[J].Hepatology,2005,42(6):1 446-1 452.
  • 5Camma C, Bruno S, Schepis F, et al. Retreatment with interferon plus ribavirin of chronic hepatitis C non- responders to interferon monotherapy: a meta- analysis of individual patient data[ J ]. Gut, 2002,51:864-869.
  • 6Papatheodoridis GV, Papadimitropoulos VC, Hsdziyannis SJ. Effect of interferon therapy on the development of hepatocellular carcinoma in patients with hepatitis C virus- reated cirrhosis: a meta- analysis[J] .Aliment Pnarmaool Ther, 2001,15:689- 698.
  • 7Kjaergard LL, Krogsgaard K, Gluud C. Interfern alfa with or without ribavirin for chronic hepatitis C: systematic review of randonmised trials[J].BMJ, 2001,323:1151 - 1155.
  • 8Alberti A, Benvegnu L. Management of hepatitis[J] .J Hepatol, 2003,38(Suppl1): S1014 - S1 18.
  • 9Poynard T, MdHutchison J, Davis GL, et al. Impact of interferon alfa - 2b and ribavirin on progression of liver fibrosiis in patients with chronic hepatitis C[J].Hepatology, 2000,32:1131 - 1137.
  • 10Booth JCL, O' Grady J, Neuberger J. Clinical guidelines on the mangement of hepatitis C[J]. Gut, 2001, 49(Suppl I ): il - i12.

共引文献761

同被引文献83

引证文献11

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部